Sirolimus-Associated Diffuse Alveolar Hemorrhage

Nicholas E. Vlahakis, Otis B. Rickman, Timothy Morgenthaler

Research output: Contribution to journalArticle

55 Scopus citations

Abstract

Sirolimus is an immunosuppressive medication used in transplant recipients. To our knowledge, we describe the third reported case of alveolar hemorrhage in association with sirolimus. Fever, dyspnea, hemoptysis, and lung infiltrates resolved rapidly with cessation of sirolimus therapy both initially and after reinstitution of the drug. Unlike previous reports, our patient had no evidence of lymphocytic alveolitis but rather marked macrophage hemosiderosis, suggesting that sirolimus pulmonary toxicity may manifest through 2 separate mechanisms. Our case highlights an uncommon but potentially lethal manifestation of sirolimus pulmonary toxicity.

Original languageEnglish (US)
Pages (from-to)541-545
Number of pages5
JournalMayo Clinic proceedings
Volume79
Issue number4
DOIs
StatePublished - Apr 2004

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Sirolimus-Associated Diffuse Alveolar Hemorrhage'. Together they form a unique fingerprint.

  • Cite this